We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Could Brexit crush 5%+ yields at GlaxoSmithKline plc and at Admiral Group plc?

Would Brexit turmoil cause GlaxoSmithKline plc (LON:GSK) and Admiral Group plc (LON:ADM) to cut their dividend payouts?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The latest polls and betting odds suggest that the outcome of next week’s EU referendum will be very finely balanced. If you’re an income investor, it could be worth asking whether any of the dividends in your portfolio are likely to be affected by a Brexit.

Safe as houses?

Pharma giant GlaxoSmithKline (LSE: GSK) is a Neil Woodford favourite, and a fixture in many investors’ income portfolios. The stock’s current 5.7% forecast yield is well above the FTSE 100 average of 4%.

XXX

Glaxo shares have outperformed the market and made modest gains so far in 2016, as the outlook for the group has improved. Core earnings per share rose by 14% during the first quarter, compared to the same period last year.

Glaxo now expects full-year core earnings growth of between 10% and 12%, suggesting a full-year figure of about 85p per share. This should be enough to cover the firm’s guided dividend of 80p per share.

Although some risks remain for Glaxo shareholders, in my view Brexit isn’t one of them. Glaxo operates in most of the world’s major economies and currencies. The firm’s business is built around its portfolio of unique products, most of which have patent protection.

I can’t see any logical reason why a UK vote to leave the EU would be likely to have a material effect on Glaxo’s sales, or its ability to pay a reliable dividend. In my view, any short-term dips as a result of the referendum could be a good buying opportunity.

Will insurance be affected?

Shares in motor insurance group Admiral Group (LSE: ADM) have risen by 25% over the last year. The FTSE 100 has fallen by 11% over the same period, making Admiral a clear winner. But while Admiral’s shares surged higher following the group’s results in March, progress since then has been uncertain.

One reason for this may simply be that Admiral’s shares now look quite fully priced. Earnings per share are expected to be flat this year and to rise by a relatively modest 6% in 2017. Set against this level of growth, I think Admiral’s 2016 forecast P/E of 17.4 is probably high enough.

However, Brexit fears may also be playing a part. The group has insurance or price comparison businesses in France, Spain and Italy. None of these make much money for the group at the moment, but international expansion is a key part of Admiral’s growth strategy.

A Brexit vote could potentially make it harder for UK companies to run regulated financial businesses in Europe. Personally, I suspect this wouldn’t be a big issue, but it’s definitely a risk. We simply don’t know how an EU exit would be handled.

Given all of this, how safe is Admiral’s dividend? The firm’s total payout is expected to be 112.7p per share this year, giving a forecast yield of 6.2%.

My view is that while Admiral is banking on its European and US operations for future growth, the current dividend is funded by Admiral’s UK business. I don’t see any reason why a Brexit would have an immediate impact on Admiral’s dividend.

Roland Head owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »